Palifermin for General Oncology Patients

Palifermin is a type of recombinant human cell growth factor that stimulates epithelial cell proliferation and differentiation. It also has direct cytoprotective effects. Palifermin has been studied in patients with cancer for the prevention and management of mucositis.

Guideline / Expert Opinion